| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/23/2023 | Kenvue Inc. | | Other (disposition) | Common Stock | 1533.8M | $0.00 | $0 | | 08/23/2023 |
| 07/02/2021 | CVRx, Inc. | CVRX | Conversion | Series E-2 Preferred Stock | 6.5M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 07/02/2021 |
| 07/02/2021 | CVRx, Inc. | CVRX | Conversion | Common Stock | 3.5M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 07/02/2021 |
| 07/02/2021 | CVRx, Inc. | CVRX | Conversion | Series D-2 Preferred Stock | 4M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 07/02/2021 |
| 07/02/2021 | CVRx, Inc. | CVRX | Conversion | Series F-2 Preferred Stock | 7.6M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 07/02/2021 |
| 07/02/2021 | CVRx, Inc. | CVRX | Conversion | Series G Preferred Stock | 48.1M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 07/02/2021 |
| 06/30/2020 | Fusion Pharmaceuticals Inc. | FUSN | Conversion | Common Shares | 2.9M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 06/30/2020 |
| 06/30/2020 | Fusion Pharmaceuticals Inc. | FUSN | Purchase | Common Shares | 725k | $17.00 | $12.3M | By Johnson & Johnson Innovation - JJDC, Inc. | 06/30/2020 |
| 06/30/2020 | Fusion Pharmaceuticals Inc. | FUSN | Conversion | Class A Preferred Shares | 10.7M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 06/30/2020 |
| 06/30/2020 | Fusion Pharmaceuticals Inc. | FUSN | Conversion | Class B Preferred Shares | 5.1M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 06/30/2020 |
| 06/30/2020 | Fusion Pharmaceuticals Inc. | FUSN | Conversion | Warrants to purchase Class B Preferred Shares | 475.8k | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 06/30/2020 |
| 06/30/2020 | Fusion Pharmaceuticals Inc. | FUSN | Conversion | Warrants to purchase Common Shares | 89.1k | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 06/30/2020 |
| 07/19/2018 | Provention Bio, Inc. | PRVB | Conversion | Series A Preferred Stock | 2.4M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 07/19/2018 |
| 07/19/2018 | Provention Bio, Inc. | PRVB | Conversion | Common Stock | 2.4M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 07/19/2018 |
| 05/07/2018 | Inspire Medical Systems, Inc. | INSP | Conversion | Series E Preferred Stock | 1.1M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 05/07/2018 |
| 05/07/2018 | Inspire Medical Systems, Inc. | INSP | Conversion | Series F Preferred Stock | 248.6k | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 05/07/2018 |
| 05/07/2018 | Inspire Medical Systems, Inc. | INSP | Conversion | Common Stock | 197.9k | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 05/07/2018 |
| 05/07/2018 | Inspire Medical Systems, Inc. | INSP | Conversion | Common Stock | 37.4k | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 05/07/2018 |
| 11/20/2017 | ACHILLION PHARMACEUTICALS INC | ACHN | Sale | Common Stock | 18.4M | $2.75 | $50.5M | By Johnson & Johnson Innovation - JJDC, Inc. | 11/20/2017 |
| 08/29/2017 | Minerva Neurosciences, Inc. | NERV | Other (disposition) | Common Stock | 3.9M | $0.00 | $389.2 | By Johnson & Johnson Innovation - JJDC, Inc. | 08/29/2017 |
| 08/16/2016 | Protagonist Therapeutics, Inc | PTGX | Conversion | Common Stock | 965.5k | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 08/16/2016 |
| 08/16/2016 | Protagonist Therapeutics, Inc | PTGX | Conversion | Common Stock | 900.3k | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 08/16/2016 |
| 08/16/2016 | Protagonist Therapeutics, Inc | PTGX | Purchase | Common Stock | 583.3k | $12.00 | $7M | By Johnson & Johnson Innovation - JJDC, Inc. | 08/16/2016 |
| 08/16/2016 | Protagonist Therapeutics, Inc | PTGX | Conversion | Series B Preferred Stock | 14M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 08/16/2016 |
| 08/16/2016 | Protagonist Therapeutics, Inc | PTGX | Conversion | Series C Preferred Stock | 13.1M | $0.00 | $0 | By Johnson & Johnson Innovation - JJDC, Inc. | 08/16/2016 |
| 04/14/2010 | TENGION INC | TNGN | Conversion | Common Stock | 755.1k | $0.00 | $0 | Johnson & Johnson Development Corporation | 04/14/2010 |
| 04/14/2010 | TENGION INC | TNGN | Conversion | Series C Preferred Stock | 3.8M | $0.00 | $0 | By Johnson & Johnson Development Corporation | 04/14/2010 |
| 04/14/2010 | TENGION INC | TNGN | Purchase | Common Stock | 400k | $5.00 | $2M | Johnson & Johnson Development Corporation | 04/14/2010 |
| 04/14/2010 | TENGION INC | TNGN | Conversion | Series A Preferred Stock | 5M | $0.00 | $0 | By Johnson & Johnson Development Corporation | 04/14/2010 |
| 04/14/2010 | TENGION INC | TNGN | Conversion | Series B Preferred Stock | 2.2M | $0.00 | $0 | By Johnson & Johnson Development Corporation | 04/14/2010 |